Dr. E. M. Schwarzmann

Learn More
L-Dopa supplemented by a peripheral decarboxylase inhibitor is considered the most potent therapeutic regimen prolonging active life in Parkinsonian patients. The long-term benefit of therapy is limited by adverse effects, such as dyskinesia and on-off phenomena, which can be mitigated by the concomitant administration of dopamine agonists, such as(More)
The aim of this multicenter randomized prospective study in patients with early Parkinson's disease is to differentiate over a 4-year period between levodopa/benserazide monotherapy and the corresponding combination with bromocriptine by the assessment of motorial side effects, therapeutical benefit and fine motorial skills. Although there is circumstantial(More)
  • D Schwarzmann
  • Zeitschrift fur Orthopadie und ihre Grenzgebiete
  • 1987
In historical research it has been unclear until now, why J.G. Heine rather unexpectedly left Würzburg in 1828. After the evaluation of new sources it is assumed today, as opposed to past oppinion, that it was due less to an "unexpected withdrawal" psychologically decompensating, angered personality, but rather a long-planned and consequent decision by(More)
  • D Schwarzmann
  • Zeitschrift fur Orthopadie und ihre Grenzgebiete
  • 1985
The validity of the awarding of the Honorary Doctorate in Surgery to J. G. Heine, which had been questioned for a long time in the sphere of research history, was confirmed by the surprising discovery in the state archives in Munich, of his PhD certificate, dated 06. 04. 1824. The conferment of this honour upon Heine by the Faculty of Medicine at Jena was(More)
  • 1